| Full Name | Yi Sun |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 23 Years |
| Location | 506 6th St, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396158614 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 287587-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
| Robert Wood Johnson University Hospital - Somerset | Somerville, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rutgers Health-rwj Pediatric Critical Care | 1355390287 | 143 |
News Archive
Using an innovative algorithm that analyzes gene regulatory and signaling networks, Columbia University Medical Center researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
Individually tailored anti-clotting medication dosing significantly cut the rate of adverse events after non-emergent percutaneous coronary intervention (PCI) with stenting, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Stent Thrombosis study were presented as a late-breaking clinical trial.
› Verified 6 days ago
| Entity Name | Rutgers Health-rwj Pediatric Critical Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780766527 PECOS PAC ID: 1355390287 Enrollment ID: O20050119000070 |
News Archive
Using an innovative algorithm that analyzes gene regulatory and signaling networks, Columbia University Medical Center researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
Individually tailored anti-clotting medication dosing significantly cut the rate of adverse events after non-emergent percutaneous coronary intervention (PCI) with stenting, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Stent Thrombosis study were presented as a late-breaking clinical trial.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yi Sun, MD, PHD 506 6th St, Brooklyn, NY 11215-3609 Ph: (718) 780-3659 | Yi Sun, MD, PHD 506 6th St, Brooklyn, NY 11215-3609 Ph: (718) 780-3659 |
News Archive
Using an innovative algorithm that analyzes gene regulatory and signaling networks, Columbia University Medical Center researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of 8.75 million shares of its common stock at a price of $4.00 per share which will result in gross proceeds of $35 million.
Individually tailored anti-clotting medication dosing significantly cut the rate of adverse events after non-emergent percutaneous coronary intervention (PCI) with stenting, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Stent Thrombosis study were presented as a late-breaking clinical trial.
› Verified 6 days ago
Mrs. Elena Agranovsky, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1857 86th St, Brooklyn, NY 11214 Phone: 718-232-1515 Fax: 718-232-1550 | |
Dr. Charles Y. Shao, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 450 Clarkson Ave, Box 25, Brooklyn, NY 11203 Phone: 718-270-6755 Fax: 718-270-3313 | |
Irina Meisher, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2601 Ocean Pkwy, Brooklyn, NY 11235 Phone: 718-616-4408 Fax: 718-616-4105 | |
Mr. Archinto Peter Anzil, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 943 President St, Brooklyn, NY 11215 Phone: 718-622-4482 | |
Anne-marie Desrosiers, Pathology Medicare: Not Enrolled in Medicare Practice Location: 1545 Atlantic Ave, Brooklyn, NY 11213 Phone: 718-613-4000 | |
Dr. Hongbei Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 450 Clarkson Avenue, Department Of Pathology, Box 25, Brooklyn, NY 11203 Phone: 718-270-4522 | |
Kathleen Rose Mccubbin, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 599 Winthrop St, Brooklyn, NY 11203 Phone: 718-604-4464 |